Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 82615

10 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
April 08, 2019
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Customceutical Compounding

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

10 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 10

BPlex (METHYLCOBALAMIN 1000 MCG/ML PYRIDOXAL 5 PHOSPHATE 20MG/ML DEXPANTHENOL 250MG/ML), 10 ML MULTIDOSE VIAL MDV INJ COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

D-1253-2019
Recall number
D-1253-2019
Initiated
April 08, 2019
Classification
Class II
Status
Terminated
Quantity
32 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Code information

Lot #: 02082019@9, Exp 5/19/19

Distribution pattern

U.S.A. Nationwide

drug · product 2 of 10

BPlex (METHYLCOBALAMIN 1000 MCG/ML PYRIDOXAL 5 PHOSPHATE 20MG/ML DEXPANTHENOL 250MG/ML), 10 ML MULTIDOSE VIAL MDV INJ COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

D-1254-2019
Recall number
D-1254-2019
Initiated
April 08, 2019
Classification
Class II
Status
Terminated
Quantity
19 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Code information

Lot #: 03122019@31, Exp 6/10/19

Distribution pattern

U.S.A. Nationwide

drug · product 3 of 10

Glutathione 200mg/mL inj. a) 10 ML and b) 12 ML MULTIDOSE VIAL MDV Compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

D-1255-2019
Recall number
D-1255-2019
Initiated
April 08, 2019
Classification
Class II
Status
Terminated
Quantity
4 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Code information

Lot #: 02132019@25, Exp 5/14/19

Distribution pattern

U.S.A. Nationwide

drug · product 4 of 10

HCG (CHORIONIC GONADOTROPIN 1000 IU/ML PEP 25 mg/mL) inj 5 mL multidose vial compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

D-1256-2019
Recall number
D-1256-2019
Initiated
April 08, 2019
Classification
Class II
Status
Terminated
Quantity
12 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Code information

Lot #: 03132019@23, Exp 5/12/19

Distribution pattern

U.S.A. Nationwide

drug · product 5 of 10

Lipoplex (METHIONINE 25 MG/ML INOSITOL 50 MG/ML CHOLINE CHLORIDE 50 MG/ML HYDROXOCOBALAMIN 500 MC/ML DEXPANTHENOL 50 MG/ML PYRIDOXINE HCL 50 MG/ML), 10 ML MULTIDOSE VIAL INJ COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

D-1257-2019
Recall number
D-1257-2019
Initiated
April 08, 2019
Classification
Class II
Status
Terminated
Quantity
16 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Code information

Lot #: 02212019@13, Exp 5/22/19

Distribution pattern

U.S.A. Nationwide

drug · product 6 of 10

Test D (TESTOSTERONE CYPIONATE 200MG/ML VITAMIN D3 5,000IU/ML), 5 ML MULTIDOSE VIAL COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

D-1258-2019
Recall number
D-1258-2019
Initiated
April 08, 2019
Classification
Class II
Status
Terminated
Quantity
8 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Code information

Lot #: 01232019@25, Exp 4/23/19

Distribution pattern

U.S.A. Nationwide

drug · product 7 of 10

Test D (TESTOSTERONE CYPIONATE 200MG/ML VITAMIN D3 5,000IU/ML), 5 ML MULTIDOSE VIAL COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

D-1259-2019
Recall number
D-1259-2019
Initiated
April 08, 2019
Classification
Class II
Status
Terminated
Quantity
2 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Code information

Lot #: 03132019@28, Exp 6/11/19

Distribution pattern

U.S.A. Nationwide

drug · product 8 of 10

Test PROCYP (TESTOSTERONE CYPIONATE 200MG/ML TESTOSTERONE PROPIONATE 20MG/ML), 5 ML MULTIDOSE VIAL INJ COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

D-1260-2019
Recall number
D-1260-2019
Initiated
April 08, 2019
Classification
Class II
Status
Terminated
Quantity
5 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Code information

Lot #: 03112019@10, Exp 6/19/19

Distribution pattern

U.S.A. Nationwide

drug · product 9 of 10

Trimix HIGH (Papaverine HCl 30 mg/mL Phentolamine Mesylate 2 mg/mL Alprostadil 20 mcg/mL), 2 mL multidose vial MDV Inj. Compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

D-1261-2019
Recall number
D-1261-2019
Initiated
April 08, 2019
Classification
Class II
Status
Terminated
Quantity
3 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Code information

Lot #: 02182019@27, Exp 8/02/19

Distribution pattern

U.S.A. Nationwide

drug · product 10 of 10

TriMix MEDIUM (Papaverine HCL 21 mg/mL Phentolamine Mesylate 0.7 mg/mL Alprostadil 7 mcg/mL), 2 mL multidose MDV Inj. Compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

D-1262-2019
Recall number
D-1262-2019
Initiated
April 08, 2019
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Code information

Lot #: 02182019@22, Exp 8/02/19

Distribution pattern

U.S.A. Nationwide